Gilaad Kaplan

Professor

University of Calgary

Canada

Research Interests

Explore related searches

Professors in Canada

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Gilaad Kaplan is a Professor at the University of Calgary, Canada. His research areas focus on inflammatory bowel disease management, the safety of COVID-19 vaccines in individuals with immune-mediated inflammatory diseases, and the association between celiac disease and other health conditions. He has published extensively on topics such as the impact of IBD medications on COVID-19 outcomes and meta-analyses related to post-polypectomy bleeding.

Articles (13)

Year:

2025

Year:

2024

Year:

2024

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (2)

Carol Hitchon

University of Manitoba

CANADA

View details

Paul R. Fortin

Université Laval Faculté de médecine

CANADA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Gilaad Kaplan

Research Interests

Explore related searches

Contact this professor

About

Articles (13)

Shaping the future of inflammatory bowel disease: a global research agenda for better management and public health response

How Safe Are COVID-19 Vaccines in Individuals with Immune-Mediated Inflammatory Diseases? The SUCCEED Study

Methotrexate and Tumor Necrosis Factor Inhibitors Independently Decrease Neutralizing Antibodies after SARS-CoV-2 Vaccination: Updated Results from the SUCCEED Study

Prophylactic clipping to prevent delayed colonic post-polypectomy bleeding: meta-analysis of randomized and observational studies

An International Reporting Registry of Patients With Celiac Disease and COVID-19: Initial Results From SECURE-CELIAC

Association Between Celiac Disease and Autism Spectrum Disorder: A Systematic Review

Effect of IBD medications on COVID-19 outcomes: results from an international registry

Impact of major depression and antidepressant use on alcoholic and non-alcoholic fatty liver disease: A population-based study

Implications of COVID-19 for patients with pre-existing digestive diseases: an update Comment

Increased Incidence of Inflammatory Bowel Disease After Hirschsprung Disease: A Population-based Cohort Study

Residential Greenspace in Childhood Reduces Risk of Pediatric Inflammatory Bowel Disease: A Population-Based Cohort Study

Risk of adverse events associated with upper and lower endoscopic ultrasound: a population-based cohort study

Smoking May Reduce the Effectiveness of Anti-TNF Therapies to Induce Clinical Response and Remission in Crohn's Disease: A Systematic Review and Meta-analysis

Collaborators (2)

Carol Hitchon

Paul R. Fortin

Make your next move.